ECP 2022 Final Programme

Tuesday, 6 Sept 61 Scientific Programme a Tuesday ECP 2022 Basel 010 16:15–16:25 Molecular genetics and immunostaining of relapsing inoperable meningiomas located at the base of skull (BS) or in frontal areas, before radiotherapy Mohammed Alshemeili, France M. Barritault, D. Poncet, E. Jouanneau, D. Meyronet 011 16:25–16:35 miR-196b-5p and miR-107 expression differentiates ocular sebaceous carcinoma from squamous cell carcinoma of the conjunctiva Robert M. Verdijk, The Netherlands R. de Keizer, A. Vriends, G. Hötte, D. Paridaens, E. Wiemer 012 16:35–16:45 Audit of outcomes for metastatic uveal melanoma patients in Ireland Ciara Hegarty, Ireland K. Kulakova, N. Walsh, C. Hui, S. Kennedy SY-15 Symposium 14:45–16:45 Rio Cytopathology: Recent advances in molecular cytopathology Chairs: Giancarlo Troncone, Italy Philippe Vielh, France 001 14:45–14:50 Introduction to the session Giancarlo Troncone, Italy 002 14:50–15:15 NGS in salivary glands Niels Rupp, Switzerland 003 15:15–15:40 Tumour molecular board Fernando Schmitt, Portugal 004 15:40–16:05 Challenges of small tissue samples for NGS Spasenija Savic-Prince, Switzerland 005 16:05–16:30 TMA in cytology Elena Vigliar, Italy 006 16:30–16:45 Q&A PL-01 Plenary Oral Free Paper Session 16:45–17:30 E-Poster Terminal 1 Chairs: Aleš Ryška, Czech Republic Gieri Cathomas, Switzerland SC-13 Short Course 17:30–19:30 San Francisco Digestive Diseases Pathology (Liver): Immune-mediated liver disorders Chairs: Peter Schirmacher, Germany Sanjay Kakar, USA 001 17:30–18:00 Liver and immunity: an overview Pietro Invernizzi, Italy 002 18:00–18:30 Autoimmune hepatitis Maria Guido, Italy 003 18:30–19:00 PBC and PSC Dina Tiniakos, United Kingdom 004 19:00–19:30 Drug-induced liver injury Yoh Zen, United Kingdom SPEC-09 Special Session 17:30–19:30 Singapore Special Session ESP AI Task Force: Task Force “AI in Pathology” Chairs: Jeroen van der Laak, The Netherlands Darren Treanor, United Kingdom 001 17:30–17:50 Introduction of the Task Force Jeroen van der Laak, The Netherlands 002 17:50–18:30 Quality management for digital pathology David Brettle, United Kingdom 003 18:30–19:10 Ethics on AI in pathology Rouven Porz, Switzerland 004 19:10–19:30 How to proceed from here? Jeroen van der Laak, The Netherlands

RkJQdWJsaXNoZXIy Mzg2Mjgy